Clinical Trial Update: Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

View source ↗

Summary

This clinical trial update discusses approaches to treating chronic Hepatitis C in Pakistan and outlines strategies to prevent antiviral drug resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Queen Mary University of London | Conditions: Hepatitis C, Chronic | Status: RECRUITING